the efficacy and tolerance of treatment with an 8-alpha-amino-ergoline derivative cu32-o85 , mesulergine , were compared with levodopa/benserazide ( madopar ) in a 3 month double-blind controlled trial in 31 patients with parkinson 's disease , not previously treated with levodopa .
C0030567
parkinson 's disease
C0023570
levodopa